Comparison of Immunogenicity and Safety of Inactivated, Adenovirus-Vectored, and Heterologous Adenovirus-Vectored/mRNA Vaccines in Patients with Systemic Lupus Erythematosus and Rheumatoid Arthritis: A Prospective Cohort Study

Background: Impaired immune responses to COVID-19 vaccines have been observed in autoimmune rheumatic disease patients. Determining the most effective and safe vaccine regimen is critically needed in such a population. We aim to compare the immunogenicity and safety of three COVID-19 vaccine regimen...

وصف كامل

التفاصيل البيبلوغرافية

الحاوية / القاعدة:	Vaccines
المؤلفون الرئيسيون:	Theerada Assawasaksakul, Tanat Lertussavavivat, Seelwan Sathitratanacheewin, Nont Oudomying, Preeyaporn Vichaiwattana, Nasamon Wanlapakorn, Yong Poovorawan, Yingyos Avihingsanon, Nawaporn Assawasaksakul, Supranee Buranapraditkun, Wonngarm Kittanamongkolchai
التنسيق:	مقال
اللغة:	الإنجليزية
منشور في:	MDPI AG 2022-05-01
الموضوعات:	immunogenicity safety reactogenicity SARS-CoV-2 vaccine SLE RA
الوصول للمادة أونلاين:	https://www.mdpi.com/2076-393X/10/6/853